MAPT and Alzheimer disease: Furthermore, in rodent models of AD neuropathology, the intake of a HFD generally aggravates cognitive performance and brain Aβ pathology, while effects on tau and synaptic markers, including synaptophysin and syntaxin-3, are less consistent [115, 149, 153, 156-163].